when did you start losing weight on tirzepatide What to Know Before Starting for Medical Loss Tirzepatide before and after: realistic

SURMOUNT-5: The Head-to-Head Trial The SURMOUNT-5 trial compared Zepbound and Wegovy directly over 72 weeks in 751 adults with obesity or overweight, without diabetes

Maintaining a rotation pattern, such as left abdomen one week, right abdomen the next, then left thigh, right thigh, keeps each site fresh

Regular monitoring should include: Blood pressure measurements at follow-up visits Assessment of heart rate and rhythm Evaluation for symptoms of cardiovascular decompensation Periodic review of cardiovascular risk factors and comorbidities Patients with heart failure require special consideration

The GIP component works to further regulate blood sugar and lipid metabolism

It does matter where you inject tirzepatide, but primarily for safety and comfort rather than differences in efficacy

Yes, tirzepatide is FDA-approved without restriction to any particular line of therapy and can be used as monotherapy or in combination with other diabetes medications